Evaluation of the Vasoconstriction Properties of MC2-01 Cream

NCT03758365 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasoconstriction

Interventions

DRUG: MC2-01 Cream
DRUG: Clobetasol Propionate 0.05% Lotion
DRUG: Betamethasone Dipropionate 0.05% Cream
DRUG: Triamcinolone Acetonide 0.1% Cream
DRUG: Hydrocortisone Butyrate 0.1% Cream
DRUG: Desonide 0.05% Cream
DRUG: Vehicle

Sponsor

MC2 Therapeutics